<DOC>
	<DOCNO>NCT02922530</DOCNO>
	<brief_summary>The overall goal research proposal develop adjunct standard treatment 'correct ' disrupt neural circuitry Parkinson 's Disease ( PD ) patient . Directly treat core deficit via targeted behavioral training slow progression PD , assure great resilience future decline , improve quality life many living PD . The purpose exploratory research study determine benefit , , mobile device-based treatment describe individual PD .</brief_summary>
	<brief_title>Piloting Novel , Mobile Cognitive Tracking Training Tool Patients With Parkinson 's Disease ( PD )</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Participants must meet diagnostic criterion Parkinson 's Disease mildtomoderate stage Participants must fluent English speaker Participants must capability complete study assess intact global cognition Participants must able engage computerized cognitive task require study Participants must normal vision ( correct normal vision ) Participants must adequate hearing acuity Participants must motor capacity use iPad mobile device Participants must willing commit time requirement study Participants must obtain benefit dopaminergic treatment ( dopamine agonist levodopa ) stable dose least one month prior screen Participant must access wireless internet connectivity Participant must least mild depression assess Beck Depression Inventory ( BDIII ) Participants unable perform neuropsychological assessment opinion evaluate staff person Participants comprehend follow instruction , opinion consent staff person Participants capable give informed consent , opinion consent staff person Participants show sign intoxication due current substance abuse ( include alcohol and/or illegal drug ) person visit Participants history significant medical disease multiple neurological event head Participants serious unstable medical illness Participants history current diagnosis follow Diagnostic Statistical Manual Mental Disorders ( DSM5 ) psychiatric illness : organic mental disorder , schizophrenia , schizoaffective disorder , delusional disorder , psychotic disorder otherwise specific , bipolar disorder , substance dependence , substance abuse ( &lt; 1 year ) ( subject cooccurring posttraumatic stress disorder relate disorder eligible participation ) diagnose medical history Participants history seizure disorder Participants pregnant Participants experience frequent fall ( several time week ) Participants severe dyskinesia Participants active suicidal ideation behavior measure ColumbiaSuicide Severity Rating Scale ( CSSRS ) Participants enrol concurrent clinical trial involve investigational pharmaceutical , nutraceutical , medical device , behavioral treatment could affect outcome study Participant use computerbased cognitive training program use within month consent date</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>